Fei Liu

Fei Liu has a long history of work experience in the scientific field. In 2005, they began their career as a Postdoctoral Scholar at the Neuroscience Research Institute of UC Santa Barbara. Fei then moved to Harvard School of Public Health in 2007, where they served as a Research Fellow - Scientist. In 2013, they began working at Biogen as a Scientist II. In 2016, they became a Consultant at RunLong MedTech. In 2017, they joined Q32 Bio Inc. (formerly Admirx Inc.) as a Sr Scientist. Finally, in 2020, they were promoted to Associate Director and Principal Scientist at Q32 Bio Inc.

Fei Liu attended Tsinghua University from 1993 to 1998, where they received their Bachelor of Engineering (B.Eng.) in Chemical Engineering. Fei then continued their studies at the University of Notre Dame, where they earned their Master's degree in Chemical Engineering in 2003, and their PhD in Chemical and Biomolecular Engineering in 2005.